Abstract

The mammalian STE20-like protein kinase 1 (MST1)-MOB kinase activator 1 (MOB1) complex has been shown to suppress the oncogenic activity of Yes-associated protein (YAP) in the mammalian Hippo pathway, which is involved in the development of multiple tumors, including pancreatic cancer (PC). However, it remains unclear whether other MST-MOB complexes are also involved in regulating Hippo-YAP signaling and have potential roles in PC. Here, we report that mammalian STE20-like kinase 4 (MST4), a distantly related ortholog of the MST1 kinase, forms a complex with MOB4 in a phosphorylation-dependent manner. We found that the overall structure of the MST4-MOB4 complex resembles that of the MST1-MOB1 complex, even though the two complexes exhibited opposite biological functions in PC. In contrast to the tumor-suppressor effect of the MST1-MOB1 complex, the MST4-MOB4 complex promoted growth and migration of PANC-1 cells. Moreover, expression levels of MST4 and MOB4 were elevated in PC and were positively correlated with each other, whereas MST1 expression was down-regulated. Because of divergent evolution of key interface residues, MST4 and MOB4 could disrupt assembly of the MST1-MOB1 complex through alternative pairing and thereby increased YAP activity. Collectively, these findings identify the MST4-MOB4 complex as a noncanonical regulator of the Hippo-YAP pathway with an oncogenic role in PC. Our findings highlight that although MST-MOB complexes display some structural conservation, they functionally diverged during their evolution.

Highlights

  • The mammalian STE20-like protein kinase 1 (MST1)–Mps one binder (MOB) kinase activator 1 (MOB1) complex has been shown to suppress the oncogenic activity of Yes-associated protein (YAP) in the mammalian Hippo pathway, which is involved in the development of multiple tumors, including pancreatic cancer (PC)

  • Given the phylogenetic classification of MST kinases and the fact that MST1/2 kinases form a complex with MOB kinase activator 1 (MOB1) in the Hippo–YAP pathway, we hypothesized that mammalian STE20-like kinase 4 (MST4) kinase may utilize the MOB family of proteins as adaptor or partner

  • Because both MST4 and MOB4 have been identified as components of the STRIPAK complex, we reasoned that MST4 and MOB4 could form a complex analogous to the MST1/2–MOB1 complex

Read more

Summary

ARTICLE cro

The mammalian STE20-like protein kinase 1 (MST1)–MOB kinase activator 1 (MOB1) complex has been shown to suppress the oncogenic activity of Yes-associated protein (YAP) in the mammalian Hippo pathway, which is involved in the development of multiple tumors, including pancreatic cancer (PC) It remains unclear whether other MST–MOB complexes are involved in regulating Hippo–YAP signaling and have potential roles in PC. Because of divergent evolution of key interface residues, MST4 and MOB4 could disrupt assembly of the MST1–MOB1 complex through alternative pairing and thereby increased YAP activity These findings identify the MST4 –MOB4 complex as a noncanonical regulator of the Hippo–YAP pathway with an oncogenic role in PC. The MST4 –MOB4 complex represents a new regulator of the Hippo–YAP pathway that coevolved with the MST1–MOB1 complex

Results
Key interface residues determine alternative pairing of MSTs with MOBs
Discussion
Plasmids and antibodies
Protein expression and purification
MBP pulldown assay
Immunoprecipitation and immunoblot analysis
MTT assay
Transwell migration assay
Tissue microarray and IHC staining
Immunofluorescence assay
Statistical analysis
Accession codes
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call